CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Renata Limited Company Snapshot
Renata Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Renata Limited with three other pharmaceutical manufacturers in Asia: Pfizer Limited of INDIA (2020 sales of 21.52 billion Indian Rupees [US$289.40 million] of which 100% was Pharmaceuticals.), Guangdong Zhongsheng Pharmaceutical Co Ltd of CHINA (1.90 billion Chinese Renmimbi [US$292.53 million] of which 95% was Medicine Manufacture), and China Chemical and Pharmaceutical Company Limited which is based in TAIWAN (8.18 billion Taiwanese Dollars [US$292.23 million] of which 73% was Taiwan).

Sales Analysis. During the third fiscal quarter of 2021, sales at Renata Limited totalled 6.50 billion Bangladeshi Taka. This is practically unchanged from the previous year, and is only an increase of 0.4% from the 6.48 billion Bangladeshi Taka in sales at the company during the third quarter of 2020. During the first three quarters of 2021, sales totalled 21.04 billion Bangladeshi Taka, which is 10.2% higher than through the first three fiscal quarters of 2020. There appears to be at least some degree of seasonality in the sales at Renata Limited: during 5 of the previous 6 fiscal years, sales were highest during the fourth quarter. The exception to this was during 2020, when the third quarter was the best quarter, accounting for 26% of sales (during that same year, the fourth quarter accounted for 23% of sales). Renata Limited reported sales of 24.67 billion Bangladeshi Taka (US$291.41 million) for the fiscal year ending June of 2020. This represents an increase of 8.2% versus 2019, when the company's sales were 22.81 billion Bangladeshi Taka. Sales at Renata Limited have increased during each of the previous five years (and since 2015, sales have increased a total of 84%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Renata Limited
  Stock Performance Chart for Renata Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (6/17/2021): 1,292.20
(Figures in Bangladeshi Taka)
1 Week 1.0%   13 Weeks -0.6%  
4 Weeks 9.0%   52 Weeks 38.5%  
 
Renata Limited Key Data:
  Ticker: RENATA Country: BANGLADESH
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 24,674,812,094
(Year Ending Jan 2021).
Employees: 8,151
  Currency: Bangladeshi Taka Market Cap: 125,922,520,105
  Fiscal Yr Ends: June Shares Outstanding: 97,448,166
  Share Type: Ordinary Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.